Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalInflammatory Bowel Diseases
Volume27
Issue number3
Pages (from-to)e37-e38
ISSN1078-0998
DOIs
Publication statusPublished - 2021

    Research areas

  • perianal fistulizing Crohn disease, ustekinumab

ID: 260306075